Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levalbuterol vs Albuterol Cardiac Safety in Critically Ill Patients
NCT01151579Phase 4Completed
- Sponsor
- Fahim Khorfan
- Start
- Dec 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of levalbuterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Fahim Khorfan. Primary endpoint: Heart Rate at 5 days. Started Dec 2008; status: completed.
02
Drugs
levalbuterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01151579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151579.